News articles about STAAR Surgical (NASDAQ:STAA) have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern rates the sentiment of press coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. STAAR Surgical earned a daily sentiment score of 0.10 on Accern’s scale. Accern also assigned news stories about the medical instruments supplier an impact score of 45.4291800044741 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Zacks Investment Research Lowers STAAR Surgical Company (STAA) to Hold (americanbankingnews.com)
- Intraocular Lens (IOL) – Medical Devices Pipeline Assessment, 2017 (rnrmarketresearch.com)
- Short Interest Declines 16.4% For STAA (thestreet.com)
- $0.02 Earnings Per Share Expected for STAAR Surgical Company (STAA) This Quarter (americanbankingnews.com)
- Canaccord Genuity Reaffirms Buy Rating for STAAR Surgical Company (STAA) (americanbankingnews.com)
A number of brokerages have recently commented on STAA. BidaskClub raised STAAR Surgical from a “strong sell” rating to a “sell” rating in a report on Friday, August 11th. Canaccord Genuity raised their price target on STAAR Surgical from $9.00 to $11.00 and gave the company a “hold” rating in a report on Thursday, August 3rd. Zacks Investment Research lowered STAAR Surgical from a “buy” rating to a “hold” rating in a report on Wednesday. TheStreet raised STAAR Surgical from a “d+” rating to a “c” rating in a report on Tuesday, August 15th. Finally, Benchmark Co. raised their price target on STAAR Surgical from $12.00 to $13.00 and gave the company a “buy” rating in a report on Monday, August 14th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $13.33.
STAAR Surgical (NASDAQ STAA) traded up 0.37% on Thursday, reaching $13.50. The company had a trading volume of 21,559 shares. STAAR Surgical has a 12 month low of $7.45 and a 12 month high of $13.95. The company’s market capitalization is $554.96 million. The company’s 50 day moving average price is $12.16 and its 200-day moving average price is $10.61.
STAAR Surgical (NASDAQ:STAA) last issued its quarterly earnings results on Wednesday, August 2nd. The medical instruments supplier reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.04. STAAR Surgical had a negative return on equity of 8.69% and a negative net margin of 6.06%. The business had revenue of $21.90 million for the quarter, compared to analyst estimates of $22.15 million. During the same quarter in the prior year, the firm posted ($0.02) earnings per share. The firm’s revenue for the quarter was up 4.8% compared to the same quarter last year. On average, equities analysts predict that STAAR Surgical will post ($0.11) earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/2955873/staar-surgical-staa-earning-somewhat-favorable-media-coverage-analysis-finds.html.
STAAR Surgical Company Profile
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.
Receive News & Ratings for STAAR Surgical Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical Company and related companies with MarketBeat.com's FREE daily email newsletter.